DexCom (NASDAQ:DXCM) Posts Earnings Results, Beats Expectations By $0.05 EPS

DexCom (NASDAQ:DXCM – Get Free Report) released its quarterly earnings data on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. DexCom had a return on equity of 31.38% and a net margin of 16.82%. The firm had revenue of $921.00 million […]

Related Keywords

United States ,Jacob Steven Leach ,Matthew Vincent Dolan ,Raymond James ,Lindbrook Capital ,Slatestone Wealth ,Canaccord Genuity Group ,Wealth Solutions ,Financial Planning Inc ,Dexcom Company Profile ,Dexcom Inc ,Citigroup ,Get Free Report ,Steven Leach ,Vincent Dolan ,Stone Wealth ,Financial Planning ,Genuity Group ,Dexcom Share ,Dexcom Real Time ,Dexcom Daily ,Dexcom ,Nasdaq Dxcm ,Dxcm ,Medical ,25213110 ,Earnings ,